Evidence map›Paper›PMID 36045222›Full record

ArticleLaboratory investigation; a journal of technical methods and pathology2022

Simultaneous metabolite MALDI-MSI, whole exome and transcriptome analysis from formalin-fixed paraffin-embedded tissue sections.

Lisa Kreutzer, Peter Weber, Theresa Heider, Mathias Heikenwälder, Tobias Riedl, Philipp Baumeister, Frederick Klauschen, Claus Belka, Axel Walch, Horst Zitzelsberger and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Laboratory investigation; a journal of technical methods and pathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Spatial Multiomics Toward Understanding Neurological Systems.Journal of mass spectrometry : JMS · 2025
    Review
  6. Article
  7. Review
  8. Quantitative mass spectrometry imaging: therapeutics & biomolecules.Chemical communications (Cambridge, England) · 2024
    Review
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Lisa KreutzerResearch Unit Radiation Cytogenetics, Helmholtz Zentrum München, Neuherberg, Germany.
Peter WeberResearch Unit Radiation Cytogenetics, Helmholtz Zentrum München, Neuherberg, Germany.
Theresa HeiderResearch Unit Radiation Cytogenetics, Helmholtz Zentrum München, Neuherberg, Germany.
Mathias HeikenwälderDivision of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Tobias RiedlDivision of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Philipp BaumeisterDepartment of Otorhinolaryngology, University Hospital, LMU Munich, München, Germany.
Frederick KlauschenFaculty of Medicine, Ludwig-Maximilians-University of Munich, Institute of Pathology, München, Germany.
Claus BelkaClinical Cooperation Group Personalized Radiotherapy in Head and Neck Cancer, Helmholtz Zentrum München, Neuherberg, Germany.
Axel WalchResearch Unit Analytical Pathology, Helmholtz Zentrum München, Neuherberg, Germany.
Horst ZitzelsbergerResearch Unit Radiation Cytogenetics, Helmholtz Zentrum München, Neuherberg, Germany.
Julia Hess *Research Unit Radiation Cytogenetics, Helmholtz Zentrum München, Neuherberg, Germany.
Kristian Unger *Research Unit Radiation Cytogenetics, Helmholtz Zentrum München, Neuherberg, Germany. unger@helmholtz-muenchen.de.
Ludwig-Maximilians-Universität München · DEHelmholtz Zentrum München · DEGerman Cancer Research Center · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Matrix-assisted laser desorption ionization mass spectrometry imaging (MALDI-MSI) allows spatial analysis of proteins, metabolites, or small molecules from tissue sections. Here, we present the simultaneous generation and analysis of MALDI-MSI, whole-exome sequencing (WES), and RNA-sequencing data from the same formalin-fixed paraffin-embedded (FFPE) tissue sections. Genomic DNA and total RNA were extracted from (i) untreated, (ii) hematoxylin-eosin (HE) stained, and (iii) MALDI-MSI-analyzed FFPE tissue sections from three head and neck squamous cell carcinomas. MALDI-MSI data were generated by a time-of-flight analyzer prior to preprocessing and visualization. WES data were generated using a low-input protocol followed by detection of single-nucleotide variants (SNVs), tumor mutational burden, and mutational signatures. The transcriptome was determined using 3'-RNA sequencing and was examined for similarities and differences between processing stages. All data met the commonly accepted quality criteria. Besides SNVs commonly identified between differently processed tissues, FFPE-typical artifactual variants were detected. Tumor mutational burden was in the same range for tissues from the same patient and mutational signatures were highly overlapping. Transcriptome profiles showed high levels of correlation. Our data demonstrate that simultaneous molecular profiling of MALDI-MSI-processed FFPE tissue sections at the transcriptome and exome levels is feasible and reliable.

Indexed as

ExomeNeoplasmsBiomarkers, TumorExome SequencingFormaldehydeGene Expression ProfilingHumansParaffin EmbeddingRNASpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationTissue FixationBiomarkers, TumorFormaldehydeRNA

Identifiers

PMID36045222
PMCPMC9708593
OpenAlexW4293770754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.